Parent Board
Sarah Pace lives in Texas with her husband Tom, daughter Emma who has a CAMK2B mutation, and daughter Hannah who is neurotypical, and as an engineer and dedicated advocate, she focuses on supporting children with CAMK2 disorders and strengthening the community through guidance and solutions.
Dina Friedman, Psy.D., is a clinical psychologist and founder of Limitless Pathways, with a focus on supporting individuals with disabilities and their caregivers. She lives in Northern Virginia with her husband, Martin, and is the mother of Sienna, who has a CAMK2A mutation, and Skyler. As a member of the CAMK2 Therapeutics Parent Advisory Board, she brings both professional expertise and lived experience to advancing research and support for affected individuals and their families.
Nikki Stusick lives in Stevensville, Michigan with her husband Turner and their 3 children Theo, Louisa, and Olive. Her son Theo is a rare disease warrior with a CAMK2D mutation. Throughout her son’s life she’s worked in rare disease advocacy in varying capacities, including as founder and executive director of The TBCK Foundation. She is grateful to work alongside the CAMK2 community in pursuit of science and support.
Staff
Scientific Advisory Board
Dr. Danielle Veenma, M.D. is a clinical geneticist and physician–scientist at Erasmus Medical Center in Rotterdam whose work includes describing and interpreting CAMK2-related neurodevelopmental disorders through detailed patient phenotyping and genotype–phenotype correlation.
Dr. Meg Stratton, Ph.D., is a professor at University of Massachuetts where she studies how CaMKII’s unique molecular properties enable synapse formation, maintenance, and long-term memory.
Dr. Kiki Chang, M.D., is a child, adolescent, and adult psychiatrist in private practice in Palo Alto and a former Stanford School of Medicine faculty member. He directed the Pediatric Bipolar Disorders Clinic and co-founded the PANS Clinic.
Florian Eichler, M.D., is a Professor of Neurology at Harvard Medical School and director of the Leukodystrophy Clinic at Massachusetts General Hospital. His research focuses on the genetics and metabolism of peroxisomal and white matter disorders.
